Lab Test

BRAF Mutation Analysis

Colon Cancer, Melanoma, Papillary Thyroid, Non-Small Cell Lung Cancer, BRAF

Test Codes

EPIC: LAB1231623

Department

Molecular Pathology

Specimen Collection Criteria

Collect: Paraffin-embedded tissue. A paraffin block must be submitted. (Slides or paraffin shavings are not acceptable.) Submit formalin-fixed, paraffin-embedded block with corresponding H&E slide. Tissue should be well fixed and well processed. Average tissue size 5.0 mm2.

  • The specimen must be accompanied by a completed requisition and must contain the patient name, date of birth, collection date, ordering physician, and source of specimen. 

Physician Office/Draw Specimen Preparation

Maintain paraffin-embedded tissue at room temperature (20-26°C or 68-78.8°F) until transport.

Preparation for Courier Transport

Transport: Paraffin-embedded tissue, at room temperature (20-26°C or 68-78.8°F).

Rejection Criteria

  • Tissue decalcified in agents other than Mol Decal (EDTA).
  • Fixatives other than 10% neutral buffered formalin.
  • Specimens fixed/processed in alternative fixatives (e.g., alcohol, zinc formalin).
  • Improper labeling or inadequate information. 
  • Less than 10 percent tumor cellularity, at discretion of medical director.
  • Poor quality and/or quantity of extracted genomic DNA.

Testing will be cancelled on specimens meeting the above criteria with client notification.

Inpatient Specimen Preparation

Specimens at Royal Oak may be sent to the Surgical Pathology tube station, #201. In-house specimens are also picked up by a Surgical Pathology assistant every hour on the hour.

In-Lab Processing

Maintain specimens at room temperature (20-26°C or 68-78.8°F) until testing.

Storage

Specimen Stability for Testing:

Room Temperature (20-26°C or 68-78.8°F): Indefinitely
Refrigerated (2-8°C or 36-46°F): Unacceptable
Frozen (-20°C/-4°F or below): Unacceptable

Specimen Storage in Department Prior to Disposal:

Residual tissue blocks are returned to the storage facility of origin when testing is complete.

Specimen Storage, DNA (post testing): 
Frozen (-25° to –15°C): Indefinitely

Laboratory

Royal Oak Clinical Molecular Pathology Laboratory

Performed

Once per week.
Results available in 10 business days.

Reference Range

No BRAF V600E mutation detected.

Test Methodology

Tissue sections are reviewed by a pathologist and relevant tumor is selected for analysis. DNA is isolated from the sample and quantified. The DNA is amplified using reagents supplied in a BRAF mutation detection kit (EntroGen, Inc., Tarzana CA). The samples are analyzed by qualitative real-time PCR. False positive or negative results may occur for reasons that include genetic variants or somatic heterogeneity of the tissue sample.

Interpretation

– Negative; No BRAF V600E mutation detected.
– Positive; BRAF V600 mutation(s) detected.

NOTES: This assay is able to detect several different mutations at the BRAF V600 locus (V600E/D/K/M/R/G) and a positive result does not indicate which specific mutation is present. The analytic sensitivity for variants other than V600E has not been established.

Clinical Utility

  • The BRAF Mutation Analysis Assay provides additional guidance in therapeutic treatment decisions for patients with metastatic colorectal adenocarcinoma, non-small lung cancer (NSCLC), malignant melanoma, thyroid carcinoma, and others.
  • As of June 2022, the targeted inhibitor combination of dabrafenib and trametinib is FDA approved for any solid tumor with the BRAF V600E mutation who have progressed following prior treatment and have no satisfactory alternative treatment options.
  • The BRAF V600E variant has been described recurrently in lung adenocarcinoma, colorectal adenocarcinoma, malignant melanoma,  thyroid carcinoma, papillary craniopharyngioma, hairy cell leukemia, Erdheim-Chester disease, and Langerhans cell histiocytosis.

CPT Codes

81210

Contacts

Last Updated

10/6/2025

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.